Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice history

Iovance Biotherapeutics Inc News

Biotechs Weakened by The Stock Market Rout

Biotechs continue to decline like tech stocks but the sector is adequately capitalized, analysts say.

Biotech Stocks Are Cheap. Is It Time for Blockbuster M&A?

Valuations for biotech stocks have slumped. This in particular opens up great opportunities for mergers and acquisitions.

Biotech Stocks Could Rally

Valuations for biotech stocks have slumped, but could rebound.

Iovance Drops After Update on Lung Cancer Treatment Study

Shares of Iovance Biotherapeutics dropped after the cancer-drug developer updated investors on its experimental lung cancer treatment.

5 Top Stock Gainers for Thursday: Iovance, Virgin Galactic

Iovance Biotherapeutics, Shoals Technologies, Virgin Galactic, Hormel Foods and Chipotle Mexican Grill are five top stock gainers for Thursday.

Breaking News

Elon Musk Throws Dogecoin a Lifeline

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

Disney Fans Angry, Excited About New Guardians of the Galaxy Ride

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora Cannabis Slashing Weed Capacity in Profitability Push

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.

Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion

Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.